CNXC · Concentrix Corp
$32.16
-0.69 (-2.10%)
At close · Sep 4
View the 10-K filed Jan 28, 2026
Customer concentration
— top 5 customers 19% of revenue
5 customers — 19% of revenue (fiscal year 2025)
“Our five largest clients collectively represented approximately 19% of our revenue in fiscal year 2025.”
5 customers — 19% of receivables (November 30, 2025)
“approximately 19% of our accounts receivable balance as of November 30, 2025 was attributable to five clients.”
Market Cap
$1.96B
Shares
61.02M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-14 | 31 | $24.87 | $771 |
| 2026-08-04 | 2,846 | $24.95 | $71,008 |
| 2026-07-31 | 3 | $24.90 | $75 |
| 2026-07-28 | 104 | $24.56 | $2,554 |
| 2026-07-24 | 57,416 | $21.94 | $1,259,707 |
| 2026-07-23 | 206,616 | $23.89 | $4,936,056 |
| 2026-07-20 | 154,595 | $24.43 | $3,776,756 |
| 2026-07-17 | 22,256 | $25.62 | $570,199 |
| 2026-07-16 | 115,030 | $24.85 | $2,858,496 |
| 2026-07-15 | 4,593 | $23.57 | $108,257 |
| 2026-07-14 | 11,272 | $24.88 | $280,447 |
| 2026-07-13 | 40,055 | $22.20 | $889,221 |
| 2026-07-10 | 49,932 | $20.97 | $1,047,074 |
| 2026-07-09 | 164,112 | $21.38 | $3,508,715 |
| 2026-07-08 | 8,362 | $22.85 | $191,072 |
| 2026-07-07 | 37,536 | $23.42 | $879,093 |
| 2026-07-06 | 201,759 | $23.60 | $4,761,512 |
| 2026-07-02 | 4,264 | $24.41 | $104,084 |
| 2026-07-01 | 95,063 | $22.41 | $2,130,362 |
| 2026-06-30 | 457,189 | $25.23 | $11,534,878 |
| 2026-06-29 | 291,907 | $25.00 | $7,297,675 |
| 2026-06-26 | 18,176 | $22.52 | $409,324 |
| 2026-06-24 | 492 | $24.34 | $11,975 |
| 2026-06-23 | 16 | $23.93 | $383 |
| 2026-06-22 | 94,340 | $25.08 | $2,366,047 |
| 2026-06-08 | 123 | $27.82 | $3,422 |
Showing 1–26 of 26 settlements
Key facts
CIK
1803599
CUSIP
20602D101
13F (30d)
171 filings
170 filers
Visit website
Investor relations